Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders

Daniel M Chopyk1, Arash Grakoui2

  • 1Emory Vaccine Center, Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, Georgia.

Gastroenterology
|June 23, 2020
PubMed

Insights

Intestinal barrier dysfunction and microbiome alterations promote liver disease. Understanding these gut-liver axis interactions is crucial for disease prevention and treatment.

Area of Science:

  • Gastroenterology and Hepatology
  • Microbiology
  • Immunology

Background:

  • The intestinal barrier, comprising physical, immunological, and microbiological components, maintains gut homeostasis.
  • Dysfunction of this barrier allows microbial translocation, triggering inflammation and liver damage.
  • The intestinal microbiome plays a critical role in regulating gut barrier integrity and host health.

Purpose of the Study:

  • To review mechanisms regulating intestinal permeability.
  • To elucidate how intestinal microbiome alterations contribute to liver disease development.
  • To discuss the disruption of intestinal barrier components in various liver diseases.

Main Methods:

  • Literature review of studies on intestinal barrier function, microbiome, and liver disease.
  • Analysis of mechanisms underlying intestinal permeability regulation.
  • Examination of the role of microbial translocation and inflammation in liver pathology.

Main Results:

  • Intestinal barrier defects and dysbiosis are key drivers of liver injury, fibrosis, cirrhosis, and cancer.
  • Microbial translocation leads to sustained inflammatory responses impacting liver health.
  • Alterations in microbial composition and function significantly affect the progression of liver diseases.

Conclusions:

  • The gut-liver axis is a critical determinant of liver health, with the intestinal barrier and microbiome playing pivotal roles.
  • Understanding these interactions offers potential therapeutic targets for preventing and treating liver diseases.
  • Further research into the gut microbiome's influence on liver pathology is warranted.

Related Concept Videos

Physiology of Enteric Nervous System and Gut Health01:05

Physiology of Enteric Nervous System and Gut Health

The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
729
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
680
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
86.2K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
815
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
233
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.2K